I Hate Dialysis Message Board
Welcome, Guest. Please login or register.
November 25, 2024, 03:20:34 AM

Login with username, password and session length
Search:     Advanced search
532606 Posts in 33561 Topics by 12678 Members
Latest Member: astrobridge
* Home Help Search Login Register
+  I Hate Dialysis Message Board
|-+  Dialysis Discussion
| |-+  Dialysis: News Articles
| | |-+  Rituximab Promotes Healing in Common Kidney Disease
0 Members and 1 Guest are viewing this topic. « previous next »
Pages: [1] Go Down Print
Author Topic: Rituximab Promotes Healing in Common Kidney Disease  (Read 1214 times)
okarol
Administrator
Member for Life
*****
Offline Offline

Gender: Female
Posts: 100933


Photo is Jenna - after Disneyland - 1988

WWW
« on: August 16, 2008, 09:14:10 AM »

Rituximab Promotes Healing in Common Kidney Disease

Fri Aug 15, 7:01 PM ET

FRIDAY, Aug. 15 (HealthDay News) -- The drug rituximab may significantly reduce kidney damage in people with a common form of kidney disease called membranous nephropathy, believed to be caused by autoimmune reactions against the kidney.

The disease, characterized by large amounts of protein in the urine, leads to impaired kidney function that may eventually require dialysis or a transplant.

Rituximab may be able to heal the damage caused by membranous nephropathy in some patients, according to a new study. The drug, originally developed as a cancer treatment for people with B cell lymphoma, selectively depletes B lymphocytes, cells that produce kidney-damaging autoantibodies.

The study included 50 patients with membranous nephropathy who were treated with rituximab. Ten of the patients eventually achieved complete remission of their disease. Kidney biopsies of seven of those 10 patients showed that deposits of autoantibodies eventually disappeared or were almost entirely reabsorbed, and there was significant healing in the kidneys.

The study will be published in the November issue of the Clinical Journal of the American Society of Nephrology.

"This represents the first demonstration that kidney injury in membranous nephropathy can regress after selective depletion of B cells. Thus, the present data provide a strong rationale for using rituximab to treat patients with membranous nephropathy," wrote Dr. Piero Ruggenenti, of the Negri Bergamo Laboratories in Italy, and colleagues.

The findings suggest that the functional and biological problems associated with membranous nephropathy can be reversed with a safe and sel ective drug, they concluded.

"Whether this may apply to other (similar kidney conditions) and may translate into long-term protection from renal function loss and the potentially life-threatening complications remains to be established," the researchers wrote.

More information

The MedlinePlus Medical Encyclopedia has more about membranous nephropathy.

http://news.yahoo.com/s/hsn/20080815/hl_hsn/rituximabpromoteshealingincommonkidneydisease
Logged


Admin for IHateDialysis 2008 - 2014, retired.
Jenna is our daughter, bad bladder damaged her kidneys.
Was on in-center hemodialysis 2003-2007.
7 yr transplant lost due to rejection.
She did PD Sept. 2013 - July 2017
Found a swap living donor using social media, friends, family.
New kidney in a paired donation swap July 26, 2017.
Her story ---> https://www.facebook.com/WantedKidneyDonor
Please watch her video: http://youtu.be/D9ZuVJ_s80Y
Living Donors Rock! http://www.livingdonorsonline.org -
News video: http://www.youtube.com/watch?v=J-7KvgQDWpU
Pages: [1] Go Up Print 
« previous next »
 

Powered by MySQL Powered by PHP SMF 2.0.17 | SMF © 2019, Simple Machines | Terms and Policies Valid XHTML 1.0! Valid CSS!